OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 37 filers reported holding OCULAR THERAPEUTIX INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $76,000 | -33.3% | 12,344 | 0.0% | 0.00% | – |
| Q2 2017 | $114,000 | +10.7% | 12,344 | +10.8% | 0.00% | – |
| Q1 2017 | $103,000 | +10.8% | 11,140 | 0.0% | 0.00% | – |
| Q4 2016 | $93,000 | +20.8% | 11,140 | 0.0% | 0.00% | – |
| Q3 2016 | $77,000 | +40.0% | 11,140 | 0.0% | 0.00% | – |
| Q2 2016 | $55,000 | -40.9% | 11,140 | +15.9% | 0.00% | – |
| Q1 2016 | $93,000 | +3.3% | 9,608 | 0.0% | 0.00% | – |
| Q4 2015 | $90,000 | -54.1% | 9,608 | -31.2% | 0.00% | -100.0% |
| Q3 2015 | $196,000 | -29.0% | 13,975 | +6.5% | 0.00% | 0.0% |
| Q2 2015 | $276,000 | -26.6% | 13,119 | +46.5% | 0.00% | -50.0% |
| Q1 2015 | $376,000 | +251.4% | 8,954 | +97.3% | 0.00% | – |
| Q4 2014 | $107,000 | +345.8% | 4,539 | +178.1% | 0.00% | – |
| Q3 2014 | $24,000 | – | 1,632 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |